Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum
暂无分享,去创建一个
Serge Batalov | Yingyao Zhou | Yingyao Zhou | E. Winzeler | M. Cassera | D. Plouffe | D. Wirth | D. Fidock | Serge Batalov | S. Volkman | D. Park | S. Westenberger | Neekesh V. Dharia | R. Eastman | Scott J Westenberger | Amar Bir Singh Sidhu | David A Fidock | David Plouffe | A. Sidhu | Selina E. Bopp | Daniel J. Park | Dyann F Wirth | Elizabeth A Winzeler | Neekesh V Dharia | María Belén Cassera | Selina ER Bopp | Rich T Eastman | Daniel J Park | Sarah K Volkman | David M. Plouffe | N. Dharia
[1] M. Cassera,et al. Effect of fosmidomycin on metabolic and transcript profiles of the methylerythritol phosphate pathway in Plasmodium falciparum. , 2007, Memorias do Instituto Oswaldo Cruz.
[2] D. Fidock,et al. Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. , 2006, The Journal of infectious diseases.
[3] Jonathan E. Allen,et al. Genome sequence of the human malaria parasite Plasmodium falciparum , 2002, Nature.
[4] Gabor T. Marth,et al. Whole-genome sequencing and variant discovery in C. elegans , 2008, Nature Methods.
[5] W. Trager,et al. Cultivation of malarial parasites , 1978, Nature.
[6] T. Richie. High road, low road? Choices and challenges on the pathway to a malaria vaccine , 2006, Parasitology.
[7] J. Wiesner,et al. Short-Course Regimens of Artesunate-Fosmidomycin in Treatment of Uncomplicated Plasmodium falciparum Malaria , 2005, Antimicrobial Agents and Chemotherapy.
[8] Pardis C Sabeti,et al. A genome-wide map of diversity in Plasmodium falciparum , 2007, Nature Genetics.
[9] Ruben Abagyan,et al. Match-Only Integral Distribution (MOID) Algorithm for high-density oligonucleotide array analysis , 2002, BMC Bioinformatics.
[10] K. Kirk,et al. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum , 2000, Nature.
[11] H. Lichtenthaler,et al. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. , 1999, Science.
[12] E. Winzeler,et al. Microarray-based comparative genomic analyses of the human malaria parasite Plasmodium falciparum using Affymetrix arrays. , 2005, Molecular and biochemical parasitology.
[13] D. Conrad,et al. Global variation in copy number in the human genome , 2006, Nature.
[14] J. P. Craig,et al. Genomic DNA sequence comparison between two inbred soybean cyst nematode biotypes facilitated by massively parallel 454 micro-bead sequencing , 2008, Molecular Genetics and Genomics.
[15] Yingyao Zhou,et al. A Systematic Map of Genetic Variation in Plasmodium falciparum , 2006 .
[16] X. Su,et al. Current understanding of the molecular basis of chloroquine-resistance in Plasmodium falciparum. , 2006, Journal of postgraduate medicine.
[17] A. Cowman,et al. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[18] K. Barry,et al. Kinetics of a new antimalarial, mefloquine , 1979, Clinical pharmacology and therapeutics.
[19] Graham F Hatfull,et al. Efficient site-specific integration in Plasmodium falciparum chromosomes mediated by mycobacteriophage Bxb1 integrase , 2006, Nature Methods.
[20] L. Feuk,et al. Detection of large-scale variation in the human genome , 2004, Nature Genetics.
[21] J. Shendure,et al. Materials and Methods Som Text Figs. S1 and S2 Tables S1 to S4 References Accurate Multiplex Polony Sequencing of an Evolved Bacterial Genome , 2022 .
[22] M. Rohmer. The discovery of a mevalonate-independent pathway for isoprenoid biosynthesis in bacteria, algae and higher plants. , 1999, Natural product reports.
[23] V. do Rosário,et al. Real-time quantitative PCR with SYBR Green I detection for estimating copy numbers of nine drug resistance candidate genes in Plasmodium falciparum , 2006, Malaria Journal.
[24] M. Cassera,et al. The Methylerythritol Phosphate Pathway Is Functionally Active in All Intraerythrocytic Stages of Plasmodium falciparum* , 2004, Journal of Biological Chemistry.
[25] Kyle T. Siebenthall,et al. Genome variation and evolution of the malaria parasite Plasmodium falciparum , 2007, Nature Genetics.
[26] J. Wiesner,et al. Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children. , 2004, The Journal of infectious diseases.
[27] Jonathan Sebat,et al. Major changes in our DNA lead to major changes in our thinking , 2007, Nature Genetics.
[28] C. Plowe,et al. Mechanisms of Resistance of Malaria Parasites to Antifolates , 2005, Pharmacological Reviews.
[29] David A. Fidock,et al. Chloroquine Resistance in Plasmodium falciparum Malaria Parasites Conferred by pfcrt Mutations , 2002, Science.
[30] Ming Yi,et al. Detection of genome-wide polymorphisms in the AT-rich Plasmodium falciparum genome using a high-density microarray , 2008, BMC Genomics.
[31] D. Fidock,et al. Gene encoding a deubiquitinating enzyme is mutated in artesunate- and chloroquine-resistant rodent malaria parasites§ , 2007, Molecular microbiology.
[32] Kenny Q. Ye,et al. Large-Scale Copy Number Polymorphism in the Human Genome , 2004, Science.
[33] John C. Wootton,et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum , 2002, Nature.
[34] Bindu Gajria,et al. PlasmoDB: The Plasmodium Genome Resource , 2005 .
[35] Thomas E. Wellems,et al. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross , 1990, Nature.
[36] D. Fidock,et al. Advances in understanding the genetic basis of antimalarial drug resistance. , 2007, Current opinion in microbiology.
[37] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[38] Peter G. Schultz,et al. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen , 2008, Proceedings of the National Academy of Sciences.
[39] François Nosten,et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number , 2004, The Lancet.
[40] H. Jomaa,et al. Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria. , 2004, The Journal of infectious diseases.
[41] G. McVean,et al. Genome-wide variation and identification of vaccine targets in the Plasmodium falciparum genome , 2007, Nature Genetics.
[42] Jun O. Liu,et al. A clinical drug library screen identifies astemizole as an antimalarial agent , 2006, Nature chemical biology.
[43] Daniel R. Richards,et al. Direct allelic variation scanning of the yeast genome. , 1998, Science.
[44] Yongyuth Yuthavong,et al. A Genetically Hard-Wired Metabolic Transcriptome in Plasmodium falciparum Fails to Mount Protective Responses to Lethal Antifolates , 2008, PLoS pathogens.
[45] J. Wootton,et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. , 2000, Molecular cell.
[46] Maitreya J. Dunham,et al. Genome-Wide Detection of Polymorphisms at Nucleotide Resolution with a Single DNA Microarray , 2006, Science.
[47] V. A. Stewart,et al. Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial , 2008, PloS one.
[48] P. Nilsson,et al. Genome wide gene amplifications and deletions in Plasmodium falciparum. , 2007, Molecular and biochemical parasitology.
[49] T. Taraschi,et al. Plasmodium falciparum: a simple, rapid method for detecting parasite clones in microtiter plates. , 1997, Experimental parasitology.
[50] D. Fidock,et al. Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[51] F. Nosten,et al. Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites. , 2006, Molecular biology and evolution.
[52] D. Fidock,et al. In Vitro Efficacy, Resistance Selection, and Structural Modeling Studies Implicate the Malarial Parasite Apicoplast as the Target of Azithromycin* , 2007, Journal of Biological Chemistry.
[53] C. Dolea,et al. World Health Organization , 1949, International Organization.
[54] F. Cohen,et al. Searching for New Antimalarial Therapeutics amongst Known Drugs , 2006, Chemical biology & drug design.
[55] P. Newton,et al. Adaptive Copy Number Evolution in Malaria Parasites , 2008, PLoS genetics.